Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5584122 | 0.83 | ALDH1A1 (0.43) | CHRM2ALDH1A1KDM4ESMN1; SMN2CYP2D6 | |
| SCHEMBL27744255 | 0.83 | ALDH1A1 (0.39) | CHRM2ALDH1A1KDM4ESMN1; SMN2LMNA | |
| SCHEMBL25607328 | 0.82 | NPC1 (0.51) | ALOX5ALDH1A1PKMCYP1A2CYP2D6 | |
| SCHEMBL394511 | 0.82 | HPGD (0.56) | ALDH1A1KDM4EL3MBTL1PKMSMN1; SMN2 | |
| SCHEMBL21612254 | 0.82 | ALDH1A1 (0.38) | CHRM2ALDH1A1KDM4ESMN1; SMN2CYP2D6 | |
| SCHEMBL10101480 | 0.82 | CNR1 (0.41) | CHRM2ALDH1A1KDM4ESMN1; SMN2 | |
| SCHEMBL15228675 | 0.81 | ALDH1A1 (0.48) | ALOX5ALDH1A1KDM4EL3MBTL1PKM | |
| SCHEMBL28023692 | 0.81 | PTGS2 (0.46) | ALDH1A1KDM4ESMN1; SMN2CYP2D6CYP2C19 | |
| SCHEMBL635088 | 0.80 | PLK1 (0.50) | ALDH1A1KDM4ESMN1; SMN2HTTLMNA | |
| SCHEMBL31038153 | 0.80 | PLK1 (0.50) | ALDH1A1KDM4ESMN1; SMN2HTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106336395-A | Benzamide derivatives containing urea bridge and preparation method and application thereof | 浙江工业大学 | 2017-01-18 | — | — | CN | disclosed |
| CN-106236751-A | The application in preparing cancer therapy drug of a kind of benzamide derivatives containing urea bridge | 浙江工业大学 | 2016-12-21 | — | — | CN | disclosed |
| US-9173400-B2 | Anthranilamide arthropodicide treatment | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-11-03 | — | — | US | disclosed |
| US-9113630-B2 | Method of controlling particular insect pests by applying anthranilamide compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-08-25 | — | — | US | disclosed |
| US-20140141972-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E I DU PONT NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | US | disclosed |
| US-20140140973-A1 | METHOD OF CONTROLLING PARTICULAR INSECT PESTS BY APPLYNG ANTHRANILAMIDE COMPOUNDS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-05-22 | — | — | US | disclosed |
| US-8697734-B2 | Method for controlling particular insect pests by applying anthranilamide compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-04-15 | — | — | US | disclosed |
| US-8637552-B2 | Anthranilamide arthropodicide treatment | E I DU PONT DE NEMOURS AND COMPANY (US) | 2014-01-28 | — | — | US | disclosed |
| EP-1467988-B1 | Quinazoline(di)ones for invertebrate pest control | DU PONT (US) | 2013-07-17 | — | — | EP | disclosed |
| US-20130031677-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-01-31 | — | — | US | disclosed |
| EP-1423379-A1 | ORTHO-SUBSTITUTED ARYL AMIDES FOR CONTROLLING INVERTEBRATE PESTS | E.I. du Pont de Nemours and Company (US) | 2004-06-02 | — | — | EP | disclosed |
| EP-1416796-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2004-05-12 | — | — | EP | disclosed |
| US-20030229050-A1 | Insecticidal anthranilamides | FMC CORPORATION | 2003-12-11 | — | — | US | disclosed |
| WO-2003062226-A1 | QUINAZOLINE(DI) ONES FOR INVERTEBRATE PEST CONTROL | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-07-31 | — | — | WO | disclosed |
| CN-1419537-A | Insecticidal anthranilamides | DU PONT (US) | 2003-05-21 | — | — | CN | disclosed |
| WO-2003024222-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-03-27 | — | — | WO | disclosed |
| WO-2003016300-A1 | ORTHO-SUBSTITUTED ARYL AMIDES FOR CONTROLLING INVERTEBRATE PESTS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-02-27 | — | — | WO | disclosed |
| WO-2003015518-A1 | METHOD FOR CONTROLLING PARTICULAR INSECT PESTS BY APPLYING ANTHRANILAMIDE COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-02-27 | — | — | WO | disclosed |
| EP-1265850-A2 | INSECTICIDAL ANTHRANILAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-12-18 | — | — | EP | disclosed |
| WO-2001070671-A2 | INSECTICIDAL ANTHRANILAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-09-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140140973-A1 | METHOD OF CONTROLLING PARTICULAR INSECT PESTS BY APPLYNG ANTHRANILAMIDE COMPOUNDS | ANTXR2, NIT2, TDO2 | ALOX5 103/4885CHRM2 348/4885ALDH1A1 2266/4885 |
| US-20130031677-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | ANTXR2, ARF5, NPR1 | ALOX5 255/4885CHRM2 493/4885ALDH1A1 933/4885 |
| US-20030229050-A1 | Insecticidal anthranilamides | ANTXR2, NIT2, CYB5R3 | ALOX5 1065/4885CHRM2 824/4885ALDH1A1 949/4885 |
| US-20140141972-A1 | ANTHRANILAMIDE ARTHROPODICIDE TREATMENT | ANTXR2, ARF5, NPR1 | ALOX5 255/4885CHRM2 493/4885ALDH1A1 933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.